Cargando…

Aberrant methylation of DACT1 and DACT2 are associated with tumor progression and poor prognosis in esophageal squamous cell carcinoma

BACKGROUND: The DACT (Dishevelled-associated antagonist of β-catenin) family of scaffold proteins may play important roles in tumorigenesis. However, the epigenetic changes of DACT1, 2, 3 and their effect on esophageal squamous cell carcinoma (ESCC) have not been investigated so far. The aim of this...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Yan-li, Shan, Bao-En, Guo, Wei, Dong, Zhi-Ming, Zhou, Zhen, Shen, Su-Peng, Guo, Xin, Liang, Jia, Kuang, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5225534/
https://www.ncbi.nlm.nih.gov/pubmed/28077137
http://dx.doi.org/10.1186/s12929-016-0308-6
_version_ 1782493525959507968
author Guo, Yan-li
Shan, Bao-En
Guo, Wei
Dong, Zhi-Ming
Zhou, Zhen
Shen, Su-Peng
Guo, Xin
Liang, Jia
Kuang, Gang
author_facet Guo, Yan-li
Shan, Bao-En
Guo, Wei
Dong, Zhi-Ming
Zhou, Zhen
Shen, Su-Peng
Guo, Xin
Liang, Jia
Kuang, Gang
author_sort Guo, Yan-li
collection PubMed
description BACKGROUND: The DACT (Dishevelled-associated antagonist of β-catenin) family of scaffold proteins may play important roles in tumorigenesis. However, the epigenetic changes of DACT1, 2, 3 and their effect on esophageal squamous cell carcinoma (ESCC) have not been investigated so far. The aim of this study was to investigate the promoter methylation and expression of DACT family, in order to elucidate more information on the role of DACT with regard to the progression and prognosis of ESCC. METHODS: MSP and BGS methods were respectively applied to examine the methylation status of DACT; RT-PCR, Western blot and immunohistochemistry methods were respectively used to determine the mRNA and protein expression of DACT; MTT, Colony-formation and Wound-healing assay were performed to assess the effect of DACT1 and DACT2 on proliferation and migration of esophageal cancer cells. RESULTS: Frequent reduced expression of DACT1, DACT2 and DACT3 were found in esophageal cancer cell lines and the expression levels of DACT1 and DACT2 were reversed by 5-Aza-Dc. Decreased mRNA and protein expression of DACT1 and DACT2 were observed in ESCC tumor tissues and were associated with the methylation status of transcription start site (TSS) region. The hypermethylation of CpG islands (CGI) shore region in DACT1 was observed both in tumor and corresponding adjacent tissues but wasn’t related to the transcriptional inhibition of DACT1. The methylation status of TSS region in DACT1 and DACT2 and the protein expression of DACT2 were independently associated with ESCC patients’ prognosis. CONCLUSIONS: The TSS region hypermethylation may be one of the main mechanisms for reduced expression of DACT1 and DACT2 in ESCC. The simultaneous methylation of DACT1 and DACT2 may play important roles in progression of ESCC and may serve as prognostic methylation biomarkers for ESCC patients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12929-016-0308-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5225534
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-52255342017-01-17 Aberrant methylation of DACT1 and DACT2 are associated with tumor progression and poor prognosis in esophageal squamous cell carcinoma Guo, Yan-li Shan, Bao-En Guo, Wei Dong, Zhi-Ming Zhou, Zhen Shen, Su-Peng Guo, Xin Liang, Jia Kuang, Gang J Biomed Sci Research BACKGROUND: The DACT (Dishevelled-associated antagonist of β-catenin) family of scaffold proteins may play important roles in tumorigenesis. However, the epigenetic changes of DACT1, 2, 3 and their effect on esophageal squamous cell carcinoma (ESCC) have not been investigated so far. The aim of this study was to investigate the promoter methylation and expression of DACT family, in order to elucidate more information on the role of DACT with regard to the progression and prognosis of ESCC. METHODS: MSP and BGS methods were respectively applied to examine the methylation status of DACT; RT-PCR, Western blot and immunohistochemistry methods were respectively used to determine the mRNA and protein expression of DACT; MTT, Colony-formation and Wound-healing assay were performed to assess the effect of DACT1 and DACT2 on proliferation and migration of esophageal cancer cells. RESULTS: Frequent reduced expression of DACT1, DACT2 and DACT3 were found in esophageal cancer cell lines and the expression levels of DACT1 and DACT2 were reversed by 5-Aza-Dc. Decreased mRNA and protein expression of DACT1 and DACT2 were observed in ESCC tumor tissues and were associated with the methylation status of transcription start site (TSS) region. The hypermethylation of CpG islands (CGI) shore region in DACT1 was observed both in tumor and corresponding adjacent tissues but wasn’t related to the transcriptional inhibition of DACT1. The methylation status of TSS region in DACT1 and DACT2 and the protein expression of DACT2 were independently associated with ESCC patients’ prognosis. CONCLUSIONS: The TSS region hypermethylation may be one of the main mechanisms for reduced expression of DACT1 and DACT2 in ESCC. The simultaneous methylation of DACT1 and DACT2 may play important roles in progression of ESCC and may serve as prognostic methylation biomarkers for ESCC patients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12929-016-0308-6) contains supplementary material, which is available to authorized users. BioMed Central 2017-01-11 /pmc/articles/PMC5225534/ /pubmed/28077137 http://dx.doi.org/10.1186/s12929-016-0308-6 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Guo, Yan-li
Shan, Bao-En
Guo, Wei
Dong, Zhi-Ming
Zhou, Zhen
Shen, Su-Peng
Guo, Xin
Liang, Jia
Kuang, Gang
Aberrant methylation of DACT1 and DACT2 are associated with tumor progression and poor prognosis in esophageal squamous cell carcinoma
title Aberrant methylation of DACT1 and DACT2 are associated with tumor progression and poor prognosis in esophageal squamous cell carcinoma
title_full Aberrant methylation of DACT1 and DACT2 are associated with tumor progression and poor prognosis in esophageal squamous cell carcinoma
title_fullStr Aberrant methylation of DACT1 and DACT2 are associated with tumor progression and poor prognosis in esophageal squamous cell carcinoma
title_full_unstemmed Aberrant methylation of DACT1 and DACT2 are associated with tumor progression and poor prognosis in esophageal squamous cell carcinoma
title_short Aberrant methylation of DACT1 and DACT2 are associated with tumor progression and poor prognosis in esophageal squamous cell carcinoma
title_sort aberrant methylation of dact1 and dact2 are associated with tumor progression and poor prognosis in esophageal squamous cell carcinoma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5225534/
https://www.ncbi.nlm.nih.gov/pubmed/28077137
http://dx.doi.org/10.1186/s12929-016-0308-6
work_keys_str_mv AT guoyanli aberrantmethylationofdact1anddact2areassociatedwithtumorprogressionandpoorprognosisinesophagealsquamouscellcarcinoma
AT shanbaoen aberrantmethylationofdact1anddact2areassociatedwithtumorprogressionandpoorprognosisinesophagealsquamouscellcarcinoma
AT guowei aberrantmethylationofdact1anddact2areassociatedwithtumorprogressionandpoorprognosisinesophagealsquamouscellcarcinoma
AT dongzhiming aberrantmethylationofdact1anddact2areassociatedwithtumorprogressionandpoorprognosisinesophagealsquamouscellcarcinoma
AT zhouzhen aberrantmethylationofdact1anddact2areassociatedwithtumorprogressionandpoorprognosisinesophagealsquamouscellcarcinoma
AT shensupeng aberrantmethylationofdact1anddact2areassociatedwithtumorprogressionandpoorprognosisinesophagealsquamouscellcarcinoma
AT guoxin aberrantmethylationofdact1anddact2areassociatedwithtumorprogressionandpoorprognosisinesophagealsquamouscellcarcinoma
AT liangjia aberrantmethylationofdact1anddact2areassociatedwithtumorprogressionandpoorprognosisinesophagealsquamouscellcarcinoma
AT kuanggang aberrantmethylationofdact1anddact2areassociatedwithtumorprogressionandpoorprognosisinesophagealsquamouscellcarcinoma